Woodford Patient Capital's three-year milestone clouded by Prothena hit

Celebrated anniversary on 21 April

Jayna Rana
clock • 3 min read

Neil Woodford's three-year anniversary since the inception of his £626m Patient Capital trust has been overshadowed by the fund's third largest holding Prothena falling 69% on Monday.

The trust reached its first track record milestone on Saturday having launched in April 2015, but just two days later, early-stage healthcare stock Prothena - which represents 9.12% of the portfolio - saw its share price slump after terminating one of its drug trials. The stock fell 69% on Monday, which was reflected onto Woodford Patient Capital through a circa 6.2% drop in NAV. In the fund's annual report, released on Tuesday, Woodford said: "Clearly not all investments we have made have developed in the direction initially envisaged. That is the nature of investing in earlier-stage...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment Trusts

Investment trusts close 2023 with 4.6% performance boost

Investment trusts close 2023 with 4.6% performance boost

Numis research into investment company universe

Cristian Angeloni
clock 04 January 2024 • 3 min read
What Q1 2023 and beyond could hold in store for markets

What Q1 2023 and beyond could hold in store for markets

Look at the road ahead, not the flies hitting the windscreen

Andrew Bell
clock 22 December 2022 • 8 min read
Fundsmith Emerging Equities trust proposes liquidation

Fundsmith Emerging Equities trust proposes liquidation

£323m Fundsmith Emerging Equities trust performance ‘fallen below expectations’

James Baxter-Derrington
clock 14 September 2022 • 1 min read